Truist Financial Corp Sees Increase in Positive Analyst Recommendations

Truist Financial Corp has experienced a recent surge in positive analyst recommendations. The company’s securities division has taken the following actions:

• Initiated a buy rating on Blue Owl Technology Finance
• Reaffirmed a buy rating on Evolent Health stock, citing favorable trends in the managed care sector
• Maintained a buy rating on several other stocks, including:
  • Nvidia
  • Mohawk Industries
  • AbCellera Biologics

These developments have contributed to a rise in the company’s stock price, which has reached a new high in recent weeks.